Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference30 articles.
1. Khorana AA, Francis CW, Culakova E, et al. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost. 2007;5:632–4.
2. Khorana AA, Dalal MR, Lin J, et al. Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the USA. Clinicoecon Outcomes Res. 2013;5:101–8.
3. Zangari M, Fink LM, Elice F, et al. Thrombotic events in patients with cancer receiving antiangiogenesis agents. J Clin Oncol. 2009;27:4865–73.
4. Lyman GH, Khorana AA, Falanga A, et al. American society of clinical oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol. 2007;25:5490–505.
5. National Comprehensive Cancer Network. (NCCN) Clinical practice guidelines in oncology:cancer-associated venous thromboembolic disease. Version 1. 2018. https://www.nccn.org/professionals/physician_gls/default.aspx#vte. Accessed 22 Mar 2018.